Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Mediolanum International Funds Ltd Reduces Holdings in Johnson & Johnson $JNJ
03:14am, Tuesday, 03'rd Feb 2026
Mediolanum International Funds Ltd reduced its stake in Johnson and Johnson (NYSE: JNJ) by 33.1% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commissi
Carrera Capital Advisors Invests $4.58 Million in Johnson & Johnson $JNJ
03:14am, Tuesday, 03'rd Feb 2026
Carrera Capital Advisors acquired a new position in Johnson and Johnson (NYSE: JNJ) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
World's #1 Selling Contact Lens Brand ACUVUE®*1 Brings Pioneering Innovation For Astigmatic Patients With Presbyopia, Providing Visual Clarity And Comfort**2
Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
04:34pm, Monday, 02'nd Feb 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, 2026. Management will participate in a Firesi
Great Lakes Advisors LLC Trims Stake in Johnson & Johnson $JNJ
06:28am, Monday, 02'nd Feb 2026
Great Lakes Advisors LLC lessened its stake in shares of Johnson and Johnson (NYSE: JNJ) by 75.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and E
Transcend Capital Advisors LLC Sells 3,486 Shares of Johnson & Johnson $JNJ
05:15am, Monday, 02'nd Feb 2026
Transcend Capital Advisors LLC decreased its position in shares of Johnson and Johnson (NYSE: JNJ) by 5.9% in the undefined quarter, according to the company in its most recent Form 13F filing with th
Where Will AbbVie Be in 5 Years?
03:45am, Monday, 02'nd Feb 2026
A prediction for AbbVie in 2031: The drugmaker will be bigger and kinglier.
Ariel Focus Fund Q4 2025 Portfolio Review
10:35am, Sunday, 01'st Feb 2026
Barrick Mining Corporation's solid liquidity supports its commitment to shareholder returns, reflected in increased share repurchases and a raise in its quarterly dividend. Johnson & Johnson's perform
Banyan Capital Management Inc. Takes Position in Johnson & Johnson $JNJ
07:08am, Sunday, 01'st Feb 2026
Banyan Capital Management Inc. acquired a new position in shares of Johnson and Johnson (NYSE: JNJ) in the third quarter, according to its most recent filing with the Securities and Exchange Commissio
Johnson & Johnson $JNJ Shares Bought by AlphaQuest LLC
07:08am, Sunday, 01'st Feb 2026
AlphaQuest LLC increased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 139.3% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 26,874 shares o
Welch & Forbes LLC Cuts Holdings in Johnson & Johnson $JNJ
07:08am, Sunday, 01'st Feb 2026
Welch and Forbes LLC lowered its holdings in Johnson and Johnson (NYSE: JNJ) by 1.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Winnow Wealth LLC Has $1.71 Million Position in Johnson & Johnson $JNJ
06:32am, Sunday, 01'st Feb 2026
Winnow Wealth LLC lifted its position in shares of Johnson and Johnson (NYSE: JNJ) by 374.4% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 9,174 shares
Everett Harris & Co. CA Has $88.90 Million Position in Johnson & Johnson $JNJ
06:32am, Sunday, 01'st Feb 2026
Everett Harris and Co. CA lessened its holdings in Johnson and Johnson (NYSE: JNJ) by 1.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exch
Atlas Private Wealth Advisors Reduces Position in Johnson & Johnson $JNJ
05:56am, Sunday, 01'st Feb 2026
Atlas Private Wealth Advisors lowered its position in Johnson and Johnson (NYSE: JNJ) by 63.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and
Tandem Investment Advisors Inc. Reduces Position in Johnson & Johnson $JNJ
05:20am, Sunday, 01'st Feb 2026
Tandem Investment Advisors Inc. trimmed its stake in Johnson and Johnson (NYSE: JNJ) by 2.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchan
